Mark Sabag, See "Remarks" at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 144,180 shares at $34.99 ($5.0M) on 2026-05-01, disclosed to the SEC on 2026-05-04.
Open-market sale of $5.0M TEVA by See "Remarks". Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TEVA | SELL | 2025-05-12 | $12.2M | — | Filing → |
| TEVA | SELL | 2025-02-14 | $5.8M | — | Filing → |
| TEVA | SELL | 2024-03-07 | $1.4M | — | Filing → |